These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6895190)

  • 1. Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.
    Arlin ZA; Flomenberg N; Gee TS; Kempin SJ; Dellaquila C; Mertelsmann R; Straus DJ; Young CW; Clarkson BD
    Cancer Clin Trials; 1981; 4(3):317-21. PubMed ID: 6895190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acridinyl anisidide (m-AMSA) therapy in 11 patients with refractory acute leukemia.
    Naparstek E; Shinar E; Polliack A
    Isr J Med Sci; 1984 Feb; 20(2):118-22. PubMed ID: 6546740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
    Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I
    Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).
    Fanucchi MP; Arlin ZA
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):27-8. PubMed ID: 6961970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
    Arlin ZA; Sklaroff RB; Gee TS; Kempin SJ; Howard J; Clarkson BD; Young CW
    Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study.
    Krischer J; Land VJ; Civin CI; Ragab AH; Mahoney DH; Frankel LS
    Cancer; 1984 Jul; 54(2):207-10. PubMed ID: 6586277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
    Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR
    Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
    Armitage JO; Burns CP
    Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I-II studies of a new antineoplastic agent, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)].
    Horikoshi N; Ogawa M; Inagaki J; Ezaki K; Inoue K; Okabe K; Nagata T; Aiba K; Domyo M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):244-9. PubMed ID: 6897858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I and II study of m-AMSA in acute leukaemia.
    Slevin ML; Shannon MS; Prentice HG; Goldman AJ; Lister TA
    Cancer Chemother Pharmacol; 1981; 6(2):137-40. PubMed ID: 6946878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults.
    Legha SS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Blood; 1982 Aug; 60(2):484-90. PubMed ID: 6953987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
    Cassileth PA; Kahn SB; Silber R; Weiler C
    Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.
    Cassileth PA; Lyman GH; Bennett JM; Glick JH; Oken MM
    Am J Clin Oncol; 1984 Aug; 7(4):361-3. PubMed ID: 6547566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
    Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
    Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.